Illness versus substance use effects on the frontal white matter in early phase schizophrenia: A 4 Tesla 1H-MRS study

被引:8
作者
Bernier, Denise [1 ]
Bartha, Robert [2 ]
McAllindon, David [1 ,3 ]
Hanstock, Christopher C. [4 ]
Marchand, Yannick [5 ]
Dillen, Kim N. H. [1 ]
Gallant, Michelle [1 ]
Good, Kimberly P. [1 ]
Tibbo, Philip G. [1 ]
机构
[1] Dalhousie Univ, Dept Psychiat, 5909 Vet Mem Lane,Abbie J Lane Bldg,Room 3030, Halifax, NS B3H 3J5, Canada
[2] Univ Western Ontario, Robarts Res Inst, London, ON N6A 3K7, Canada
[3] Biomed Translat Imaging Ctr, Halifax, NS, Canada
[4] Univ Alberta, Dept Biomed Engn, Edmonton, AB T6G 2M7, Canada
[5] Dalhousie Univ, Fac Comp Sci, Dept Psychol & Neurosci, Halifax, NS B3H 3J5, Canada
关键词
Cannabis; THC; Alcohol; myoInositol; Choline-containing compounds; Glutamate; MAGNETIC-RESONANCE-SPECTROSCOPY; CULTURED CORTICAL-NEURONS; N-ACETYLASPARTATE; USE DISORDERS; IN-VIVO; 1ST-EPISODE SCHIZOPHRENIA; PHOSPHOLIPID-METABOLISM; ANTERIOR CINGULATE; ORGANIC OSMOLYTES; BRAIN ENERGY;
D O I
10.1016/j.schres.2016.04.022
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: Young adults with early phase schizophrenia often report a past or current pattern of illicit substance use and/or alcohol misuse. Still, little is known about the cumulative and separate effects of each stressor on white matter tissue, at this vulnerable period of brain development. Methods: Participants involved 24 healthy controls with a past or current history of sustained illicit drug use and/or alcohol misuse (users), 23 healthy controls without such history (normative data), and 27 users with early phase schizophrenia. H-1-MRS data were acquired from a large frontal volume encompassing 95% of white matter, using a 4 Tesla scanner (LASER sequence, TR/TE 3200/46 ms). Results: Reduced levels of choline-containing compounds (Cho) were specific to the effect of illness (Cohen's d = 0.68), with 22% of the variance in Cho levels accounted for by duration of illness. Reduced levels of myoInositol (d = 1.10) and creatine plus phosphocreatine (d = 1.07) were specific to the effects of illness plus substance use. Effect of substance use on its own was revealed by reductions in levels of glutamate plus glutamine (d = 0.83) in control users relative to normative data. Conclusions: The specific effect of illness on white matter might indicate a decreased synthesis of membrane phospholipids or alternatively, reduced membrane cellular density. In terms of limitations, this study did not include patients without a lifetime history of substance use (non-users), and the specific effect of each substance used could not be studied separately. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:4 / 11
页数:8
相关论文
共 78 条
[21]   White matter changes in schizophrenia - Evidence for myelin-related dysfunction [J].
Davis, KL ;
Stewart, DG ;
Friedman, JI ;
Buchsbaum, M ;
Harvey, PD ;
Hof, PR ;
Buxbaum, J ;
Haroutunian, V .
ARCHIVES OF GENERAL PSYCHIATRY, 2003, 60 (05) :443-456
[22]  
de Beer R, 1992, IN VIVO MRI SPECTROS, P201, DOI DOI 10.1007/978-3-642-45697-8_7
[23]   QUALITY - QUANTIFICATION IMPROVEMENT BY CONVERTING LINESHAPES TO THE LORENTZIAN TYPE [J].
DEGRAAF, AA ;
VANDIJK, JE ;
BOVEE, WMMJ .
MAGNETIC RESONANCE IN MEDICINE, 1990, 13 (03) :343-357
[24]   Δ9-tetrahydrocannabinol induces the apoptotic pathway in cultured cortical neurones via activation of the CB1 receptor [J].
Downer, E ;
Boland, B ;
Fogarty, M ;
Campbell, V .
NEUROREPORT, 2001, 12 (18) :3973-3978
[25]  
Galinska B, 2009, MED SCI MONITOR, V15, pCR82
[26]   Dynamic mapping of human cortical development during childhood through early adulthood [J].
Gogtay, N ;
Giedd, JN ;
Lusk, L ;
Hayashi, KM ;
Greenstein, D ;
Vaituzis, AC ;
Nugent, TF ;
Herman, DH ;
Clasen, LS ;
Toga, AW ;
Rapoport, JL ;
Thompson, PM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (21) :8174-8179
[27]   A two-year follow-up study and prospective evaluation of the DSM-IV axis V [J].
Hay, P ;
Katsikitis, M ;
Begg, J ;
Da Costa, J ;
Blumenfeld, N .
PSYCHIATRIC SERVICES, 2003, 54 (07) :1028-1030
[28]   Should there be both categorical and dimensional criteria for the substance use disorders in DSM-V? [J].
Helzer, John E. ;
van den Brink, Wim ;
Guth, Sarah E. .
ADDICTION, 2006, 101 :17-22
[29]   EVALUATION OF CEREBRAL GRAY AND WHITE-MATTER METABOLITE DIFFERENCES BY SPECTROSCOPIC IMAGING AT 4.1T [J].
HETHERINGTON, HP ;
MASON, GF ;
PAN, JW ;
PONDER, SL ;
VAUGHAN, JT ;
TWIEG, DB ;
POHOST, GM .
MAGNETIC RESONANCE IN MEDICINE, 1994, 32 (05) :565-571
[30]   Microarrays and molecular research: noise discovery? [J].
Ioannidis, JPA .
LANCET, 2005, 365 (9458) :454-455